HKUMed researchers (IMAGE)

The University of Hong Kong

HKUMed researchers

Caption

HKUMed researchers develop the world’s first organoid-based platform to evaluate the therapeutic potential of neutralising antibodies in the human body, providing more reliable scientific evidence for clinical treatment. The research team includes (from right): Professor Kelvin To Kai-wang, Professor Jane Zhou Jie and Dr Li Cun.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.